Drugs / Modipafant
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1/2 | NCT02569827 Comparator | Dec 2018 → Aug 2019 | dengue disease | Singapore General Hospital | Withdrawn | No outcome recorded Stop: Business |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Modipafant | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02569827 ↗ |
| Known as | UK-80067 | ChEMBL registry synonym — accepted as the source's own label CHEMBL2105829 ↗ |
| Modality | Small molecule | — CHEMBL2105829 ↗ |